Socrates Institute for Therapeutic Immunology

The Socrates Institute for Therapeutic Immunology is a research-driven organization focused on developing immunotherapies for autoimmune diseases, most notably Type 1 Diabetes. The institute supports the work of Dr. Denise Faustman at Massachusetts General Hospital, specifically investigating the Bacillus Calmette-Guérin (BCG) vaccine's ability to reset the immune system. By inducing the production of tumor necrosis factor (TNF), the therapy aims to selectively eliminate the autoreactive T-cells responsible for attacking the pancreas. The institute's mission is to advance affordable, permanent treatments for long-term sufferers of autoimmune conditions through rigorous clinical trials. Their research also extends to other inflammatory and autoimmune conditions, including fibromyalgia and multiple sclerosis.